EcoDrugPlus

Sodium Voltage-Gated Channel Alpha Subunit 8

Ensembl ID : ENSCVAG00000005320
Gene Symbol: SCN8A
4 Cross references
218 Possible Orthologues:

Sodium- And Chloride-Dependent Gaba Transporter 1-Like

Ensembl ID : ENSCVAG00000012675
Gene Symbol: LOC107088165
3 Cross references
204 Possible Orthologues:

Sodium- And Chloride-Dependent Gaba Transporter 1-Like

Ensembl ID : ENSCVAG00000017414
Gene Symbol: LOC107102818
3 Cross references
209 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSCVAG00000007229
Gene Symbol: LOC107092682
4 Cross references
241 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSCVAG00000007111
Gene Symbol: LOC107092686
4 Cross references
232 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSCVAG00000007162
Gene Symbol: LOC107092687
3 Cross references
229 Possible Orthologues:

Sodium/hydrogen Exchanger 3-Like

Ensembl ID : ENSCVAG00000011166
Gene Symbol: LOC107098939
3 Cross references
237 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-2-Like

Ensembl ID : ENSCVAG00000010938
Gene Symbol: LOC107092351
3 Cross references
205 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-2-Like

Ensembl ID : ENSCVAG00000000053
Gene Symbol: LOC107105146
3 Cross references
190 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-233-Like

Ensembl ID : ENSCVAG00000021778
Gene Symbol: LOC107101613
3 Cross references
215 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-3-Like

Ensembl ID : ENSCVAG00000016519
Gene Symbol: LOC107102854
3 Cross references
230 Possible Orthologues:

Solute Carrier Family 18 Member A2

Ensembl ID : ENSCVAG00000000201
Gene Symbol: SLC18A2
3 Cross references
216 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).